Recurrent seizures and serotonin syndrome following "2C-I" ingestion.
Journal of medical toxicology : official journal of the American College of Medical Toxicology June 1, 2013 Adam Bosak, Frank Lovecchio, Michael Levine 59 citations
A 19-year-old male who insufflated the designer drug 2C-I developed recurrent seizures, hyperadrenergic state, and serotonin syndrome, leading to prolonged respiratory failure. Comprehensive drug testing confirmed 2C-I. The patient ultimately made a full recovery. This case highlights the potential for severe toxicity from this emerging phenethylamine, with effects including seizures and serotonin syndrome, and underscores the need for awareness among clinicians.